Ads
related to: generic advair for copd
Search results
Results from the WOW.Com Content Network
In 2012, Advair was part of a larger civil settlement agreement between GlaxoSmithKline (GSK) and the United States, in which GSK agreed to pay $1.043 billion; the United States said that GSK promoted off-label uses of Advair and paid kickbacks to healthcare professionals to sell this drug, among others. [19]
Salmeterol is a long-acting β 2 adrenergic receptor agonist (LABA) used in the maintenance and prevention of asthma symptoms and maintenance of chronic obstructive pulmonary disease (COPD) symptoms. [2] Symptoms of bronchospasm include shortness of breath, wheezing, coughing and chest tightness.
This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]
GlaxoSmithKline and its partner Theravance recently scored a second victory in their quest to treat chronic obstructive pulmonary disease, commonly abbreviated as COPD -- an umbrella term that ...
So far, GlaxoSmithKline has managed to confound generic competitors trying to copy its Advair treatment, the company's best-selling lung drug. However, this could soon be about to change after the ...
The cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and Trelegy Ellipta, and would apply to patients ...
Ads
related to: generic advair for copd